UK Markets closed

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp
Add to watchlist
4,481.50+156.50 (+3.62%)
At close: 4:39PM BST
Full screen
Previous close4,325.00
Open4,397.50
Bid4,440.00 x 6100
Ask4,500.00 x 13000
Day's range4,319.00 - 4,492.00
52-week range3,996.00 - 5,520.00
Volume4,372,237
Avg. volume2,210,788
Market cap56.72B
Beta0.67
PE ratio (TTM)16.78
EPS (TTM)267
Earnings date3 Feb 2016 - 8 Feb 2016
Dividend & yield2.80 (4.78%)
Ex-dividend date2017-02-16
1y target est68.80
  • Financial Times6 hours ago

    [$$] AstraZeneca chief demands clarity on post-Brexit landscape

    The chief executive of AstraZeneca has said uncertainty over the regulatory regime post-Brexit meant the company would "wait to see" before taking some key decisions about further investment ...

  • Reuters15 hours ago

    Moody's takes negative outlook on AstraZeneca's debt

    Moody's Investors Service said on Friday it changed its outlook on AstraZeneca Plc's long-term debt rating to negative from stable, a day after the company's closely watched advanced lung cancer trial failed. Moody's said the change in outlook reflects the increased execution risk present in the company's pipeline and the negative results of the lung cancer trial. AstraZeneca's combination of two injectable immunotherapy drugs failed to help patients as hoped in a closely watched advanced lung cancer trial, triggering the biggest ever daily fall in its shares on Thursday.

  • Moody's17 hours ago

    Zeneca Wilmington Inc. -- Moody's changes outlook on AstraZenaca's A3 rating to negative; affirms ratings

    Rating Action: Moody's changes outlook on AstraZenaca's A3 rating to negative; affirms ratings. Global Credit Research- 28 Jul 2017. London, 28 July 2017-- Moody's Investors Service has today changed to ...

By using Yahoo, you agree that Yahoo and its partners may use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more